INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inspire Medical Systems Reports Preliminary Figures for Q4 21

01/04/2022 | 04:30pm EDT


© MT Newswires 2022
All news about INSPIRE MEDICAL SYSTEMS, INC.
05/12EnsoData, Inc. announced that it has received $19.999975 million in funding from Inspir..
CI
05/11TRANSCRIPT : Inspire Medical Systems, Inc. Presents at Bank of America 2022 Healthcare Con..
CI
05/11Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
AQ
05/04INSPIRE MEDICAL SYSTEMS, INC. : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
05/04Piper Sandler Adjusts Price Target on Inspire Medical Systems to $310 From $305, Reiter..
MT
05/03TRANSCRIPT : Inspire Medical Systems, Inc., Q1 2022 Earnings Call, May 03, 2022
CI
05/03INSPIRE : Q1 Earnings Snapshot
AQ
05/03Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q1 Loss $-0.61, vs. Street Est of..
MT
05/03Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Posts Q1 Revenue $69.4M, vs. Street Est o..
MT
05/03INSPIRE MEDICAL SYSTEMS, INC. : Submission of Matters to a Vote of Security Holders (form ..
AQ
More news
Analyst Recommendations on INSPIRE MEDICAL SYSTEMS, INC.
More recommendations
Financials (USD)
Sales 2022 341 M - -
Net income 2022 -59,7 M - -
Net cash 2022 181 M - -
P/E ratio 2022 -81,5x
Yield 2022 -
Capitalization 4 853 M 4 853 M -
EV / Sales 2022 13,7x
EV / Sales 2023 10,3x
Nbr of Employees 485
Free-Float 98,0%
Chart INSPIRE MEDICAL SYSTEMS, INC.
Duration : Period :
Inspire Medical Systems, Inc. Technical Analysis Chart | INSP | US4577301090 | MarketScreener
Technical analysis trends INSPIRE MEDICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 175,90 $
Average target price 281,60 $
Spread / Average Target 60,1%
EPS Revisions
Managers and Directors
Timothy P. Herbert President, Chief Executive Officer & Director
Richard John Buchholz Chief Financial Officer
Marilyn Carlson Nelson Chairman
Philip J. Ebeling Chief Operating Officer
Bryan K. Phillips Secretary, Chief Compliance Officer & Senior VP
Sector and Competitors